Table 3.
Characteristic | PD-L1 expression | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
TC | IC | |||||||||
Negative (n, %) |
Any+ (n, %) |
P value | Negative (n, %) |
Any+ (n, %) |
P value | |||||
Age (years) | 0.579 | 0.011 | ||||||||
<60 | 12 | 50% | 12 | 50% | 15 | 63% | 9 | 38% | ||
≥60 | 11 | 41% | 16 | 59% | 7 | 26% | 20 | 74% | ||
Sex | 1 | 0.737 | ||||||||
Male | 18 | 45% | 22 | 55% | 18 | 45% | 22 | 55% | ||
Female | 5 | 45% | 6 | 55% | 4 | 36% | 7 | 64% | ||
Smoking status | 0.761 | 0.214 | ||||||||
Never smoker | 17 | 47% | 19 | 53% | 18 | 50% | 18 | 50% | ||
Smoker | 6 | 40% | 9 | 60% | 4 | 27% | 11 | 73% | ||
Pathologic stage | 1 | 0.579 | ||||||||
IIIB | 9 | 43% | 12 | 57% | 8 | 38% | 13 | 62% | ||
IV | 14 | 47% | 16 | 53% | 14 | 47% | 16 | 53% | ||
Mutation status | \ | \ | ||||||||
EGFR mutant | 1 | 50% | 1 | 50% | 1 | 50% | 1 | 50% | ||
KRAS mutant | 0 | 0% | 2 | 100% | 1 | 50% | 1 | 50% | ||
Other | 22 | 47% | 25 | 53% | 20 | 43% | 27 | 57% |